Partnerships for Development of Vaccines to Prevent Mycobacterium tuberculosis Infection and/or Disease (R01)

The purpose of this grant is to solicit research applications focused on preclinical development of lead candidate vaccines to prevent Mycobacterium tuberculosis (Mtb) infection and/or disease, and to increase the clinical pipeline of viable vaccine candidates.

applicants must demonstrate substantive investment by at least one industry participant.

Funding: $750,000 per year

Duration: 5 years 

Research Authority due date: 25.9.25

LOI (encouraged) due date: 7.10.25

Full proposal due date: 7.11.25

Please remember: 

NIH will no longer issue awards (new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts.